Retinal vein occlusion (RVO) is a universal vascular disorder of the retina and one of the typical causes of vision loss. Specifically, it is known as second most common cause of blindness from retinal disease after diabetic retinopathy
Retinal vein occlusion is a blockage in one of the veins returning blood flow from the retina. The retina is where images are converted to nerve signals. The primary symptom of retinal vein occlusion is a sudden painless change in vision. Predisposing factors are atherosclerosis, macular edema, diabetes, high blood pressure, high cholesterol and age
Click here for sample report @ https://www.wiseguyreports.com/sample-request/2593470-retinal-vein-occlusion-pipeline-review-h2-2017
Retinal Vein Occlusion Industry Major Highlights:
Retinal Vein Occlusion - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Retinal Vein Occlusion (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The report further guide in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Retinal Vein Occlusion (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage..
Major Outlook of Retinal Vein Occlusion Report:
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Retinal Vein Occlusion (Ophthalmology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Retinal Vein Occlusion (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Retinal Vein Occlusion (Ophthalmology)
The pipeline guide provides a snapshot of the global therapeutic landscape of Retinal Vein Occlusion (Ophthalmology).
- The pipeline guide reviews pipeline therapeutics for Retinal Vein Occlusion (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
Competitive Analysis for Retinal Vein Occlusion
Key players are making innovative developments in Non-Alcoholic Steatohepatitis (NASH) industry. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector.
The key players in this market are: Acucela Inc, Clearside BioMedical Inc, Formycon AG, Graybug Vision Inc, Kala Pharmaceuticals Inc, Lupin Ltd, Mabion SA, and Novartis AG.
Table of Contents
List of Tables 6
List of Figures 6
Global Markets Direct Report Coverage 7
Retinal Vein Occlusion - Overview 8
Retinal Vein Occlusion - Therapeutics Development 9
Pipeline Overview 9
Pipeline by Companies 10
Products under Development by Companies 12
Retinal Vein Occlusion - Therapeutics Assessment 14
Assessment by Target 14
Assessment by Mechanism of Action 16
Assessment by Route of Administration 18
Assessment by Molecule Type 20
Retinal Vein Occlusion - Companies Involved in Therapeutics Development 22
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2593470-retinal-vein-occlusion-pipeline-review-h2-2017
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
P: +44 208 133 9349
M: +1 646 845 9349